These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10142630)

  • 1. To have (medical devices) or not: what's safer for patients?
    McCormack J
    Health Facil Manage; 1995 Jun; 8(6):44, 46, 48. PubMed ID: 10142630
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical devices; medical device reporting; baseline reports; stay of effective date--FDA. Final rule.
    Fed Regist; 1996 Jul; 61(148):39868-9. PubMed ID: 10159600
    [No Abstract]   [Full Text] [Related]  

  • 3. A pivotal medical-device case.
    Sonder G
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18426012
    [No Abstract]   [Full Text] [Related]  

  • 4. A pivotal medical-device case.
    Greenspan H
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals and medical devices: medical devices. Year end issue brief.
    Tiffany S
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-19. PubMed ID: 18345548
    [No Abstract]   [Full Text] [Related]  

  • 6. A new public/private partnership in the interest of public health.
    Barlow WK
    Food Drug Law J; 1999; 54(3):363-6. PubMed ID: 11797703
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM
    Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed FDA "unsafe" lead wire ban could affect many medical devices.
    Hosp Technol Ser; 1995 Jul; 14(7):12-4. PubMed ID: 10144657
    [No Abstract]   [Full Text] [Related]  

  • 11. A pivotal medical-device case.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2008 Jan; 358(1):76-7. PubMed ID: 18172178
    [No Abstract]   [Full Text] [Related]  

  • 12. Who should protect the public? The Supreme Court and medical device regulation.
    Korobkin R
    N Engl J Med; 2007 Oct; 357(17):1680-1. PubMed ID: 17960010
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
    Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Watchdog group says "massive lobbying effort" by medical device industry threatens public health.
    Lenzer J
    BMJ; 2012 Feb; 344():e1521. PubMed ID: 22374926
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical device reporting: issues with Class III medical devices.
    Zigler J; Walsh J; Zigler J
    Food Drug Law J; 2007; 62(3):573-80. PubMed ID: 17915398
    [No Abstract]   [Full Text] [Related]  

  • 17. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remarketers of medical devices; review and revision of compliance policy guides and regulatory requirements; request for comments and information--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1997 Dec; 62(246):67011-3. PubMed ID: 10179309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United States laws under review.
    Leahey M
    Med Device Technol; 2007; 18(3):44-5. PubMed ID: 17585722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in regulating breakthrough medical devices.
    Muni NI; Gross TP; Boam AB; Wang S; Zuckerman BD
    Food Drug Law J; 2005; 60(2):137-42. PubMed ID: 16097092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.